Seetha Shankaran1, Abbot R Laptook2, Athina Pappas1, Scott A McDonald3, Abhik Das4, Jon E Tyson5, Brenda B Poindexter6, Kurt Schibler7, Edward F Bell8, Roy J Heyne9, Claudia Pedroza7, Rebecca Bara1, Krisa P Van Meurs10, Cathy Grisby7, Carolyn M Petrie Huitema4, Meena Garg11, Richard A Ehrenkranz12, Edward G Shepherd13, Lina F Chalak9, Shannon E G Hamrick14, Amir M Khan5, Anne Marie Reynolds15, Matthew M Laughon16, William E Truog17, Kevin C Dysart18, Waldemar A Carlo19, Michele C Walsh20, Kristi L Watterberg21, Rosemary D Higgins22. 1. Department of Pediatrics, Wayne State University, Detroit, Michigan. 2. Department of Pediatrics, Women and Infants Hospital, Brown University, Providence, Rhode Island. 3. Social, Statistical, and Environmental Sciences Unit, RTI International, Research Triangle Park, North Carolina. 4. Social, Statistical, and Environmental Sciences Unit, RTI International, Rockville, Maryland. 5. Department of Pediatrics, University of Texas Medical School at Houston. 6. Department of Pediatrics, Indiana University School of Medicine, Indianapolis. 7. Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 8. Department of Pediatrics, University of Iowa, Iowa City. 9. Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas. 10. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California. 11. Department of Pediatrics, University of California, Los Angeles. 12. Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut. 13. Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus. 14. Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia. 15. Department of Pediatrics, University at Buffalo, Buffalo, New York. 16. Division of Neonatal/Perinatal Medicine, Department of Pediatrics, University of North Carolina, Chapel Hill. 17. Department of Pediatrics, Children's Mercy Hospital, Kansas City School of Medicine, University of Missouri. 18. Department of Pediatrics, Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania. 19. Division of Neonatology, University of Alabama at Birmingham. 20. Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, Ohio. 21. University of New Mexico Health Sciences Center, Albuquerque, New Mexico. 22. Pregnancy and Perinatology Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Abstract
IMPORTANCE: Hypothermia at 33.5°C for 72 hours for neonatal hypoxic ischemic encephalopathy reduces death or disability to 44% to 55%; longer cooling and deeper cooling are neuroprotective in animal models. OBJECTIVE: To determine if longer duration cooling (120 hours), deeper cooling (32.0°C), or both are superior to cooling at 33.5°C for 72 hours in neonates who are full-term with moderate or severe hypoxic ischemic encephalopathy. DESIGN, SETTING, AND PARTICIPANTS: A randomized, 2 × 2 factorial design clinical trial performed in 18 US centers in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Neonatal Research Network between October 2010 and November 2013. INTERVENTIONS: Neonates were assigned to 4 hypothermia groups; 33.5°C for 72 hours, 32.0°C for 72 hours, 33.5°C for 120 hours, and 32.0°C for 120 hours. MAIN OUTCOMES AND MEASURES: The primary outcome of death or disability at 18 to 22 months is ongoing. The independent data and safety monitoring committee paused the trial to evaluate safety (cardiac arrhythmia, persistent acidosis, major vessel thrombosis and bleeding, and death in the neonatal intensive care unit [NICU]) after the first 50 neonates were enrolled, then after every subsequent 25 neonates. The trial was closed for emerging safety profile and futility analysis after the eighth review with 364 neonates enrolled (of 726 planned). This report focuses on safety and NICU deaths by marginal comparisons of 72 hours' vs 120 hours' duration and 33.5°C depth vs 32.0°C depth (predefined secondary outcomes). RESULTS: The NICU death rates were 7 of 95 neonates (7%) for the 33.5°C for 72 hours group, 13 of 90 neonates (14%) for the 32.0°C for 72 hours group, 15 of 96 neonates (16%) for the 33.5°C for 120 hours group, and 14 of 83 neonates (17%) for the 32.0°C for 120 hours group. The adjusted risk ratio (RR) for NICU deaths for the 120 hours group vs 72 hours group was 1.37 (95% CI, 0.92-2.04) and for the 32.0°C group vs 33.5°C group was 1.24 (95% CI, 0.69-2.25). Safety outcomes were similar between the 120 hours group vs 72 hours group and the 32.0°C group vs 33.5°C group, except major bleeding occurred among 1% in the 120 hours group vs 3% in the 72 hours group (RR, 0.25 [95% CI, 0.07-0.91]). Futility analysis determined that the probability of detecting a statistically significant benefit for longer cooling, deeper cooling, or both for NICU death was less than 2%. CONCLUSIONS AND RELEVANCE: Among neonates who were full-term with moderate or severe hypoxic ischemic encephalopathy, longer cooling, deeper cooling, or both compared with hypothermia at 33.5°C for 72 hours did not reduce NICU death. These results have implications for patient care and design of future trials. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01192776.
IMPORTANCE: Hypothermia at 33.5°C for 72 hours for neonatal hypoxic ischemic encephalopathy reduces death or disability to 44% to 55%; longer cooling and deeper cooling are neuroprotective in animal models. OBJECTIVE: To determine if longer duration cooling (120 hours), deeper cooling (32.0°C), or both are superior to cooling at 33.5°C for 72 hours in neonates who are full-term with moderate or severe hypoxic ischemic encephalopathy. DESIGN, SETTING, AND PARTICIPANTS: A randomized, 2 × 2 factorial design clinical trial performed in 18 US centers in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Neonatal Research Network between October 2010 and November 2013. INTERVENTIONS: Neonates were assigned to 4 hypothermia groups; 33.5°C for 72 hours, 32.0°C for 72 hours, 33.5°C for 120 hours, and 32.0°C for 120 hours. MAIN OUTCOMES AND MEASURES: The primary outcome of death or disability at 18 to 22 months is ongoing. The independent data and safety monitoring committee paused the trial to evaluate safety (cardiac arrhythmia, persistent acidosis, major vessel thrombosis and bleeding, and death in the neonatal intensive care unit [NICU]) after the first 50 neonates were enrolled, then after every subsequent 25 neonates. The trial was closed for emerging safety profile and futility analysis after the eighth review with 364 neonates enrolled (of 726 planned). This report focuses on safety and NICU deaths by marginal comparisons of 72 hours' vs 120 hours' duration and 33.5°C depth vs 32.0°C depth (predefined secondary outcomes). RESULTS: The NICU death rates were 7 of 95 neonates (7%) for the 33.5°C for 72 hours group, 13 of 90 neonates (14%) for the 32.0°C for 72 hours group, 15 of 96 neonates (16%) for the 33.5°C for 120 hours group, and 14 of 83 neonates (17%) for the 32.0°C for 120 hours group. The adjusted risk ratio (RR) for NICU deaths for the 120 hours group vs 72 hours group was 1.37 (95% CI, 0.92-2.04) and for the 32.0°C group vs 33.5°C group was 1.24 (95% CI, 0.69-2.25). Safety outcomes were similar between the 120 hours group vs 72 hours group and the 32.0°C group vs 33.5°C group, except major bleeding occurred among 1% in the 120 hours group vs 3% in the 72 hours group (RR, 0.25 [95% CI, 0.07-0.91]). Futility analysis determined that the probability of detecting a statistically significant benefit for longer cooling, deeper cooling, or both for NICU death was less than 2%. CONCLUSIONS AND RELEVANCE: Among neonates who were full-term with moderate or severe hypoxic ischemic encephalopathy, longer cooling, deeper cooling, or both compared with hypothermia at 33.5°C for 72 hours did not reduce NICU death. These results have implications for patient care and design of future trials. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01192776.
Authors: Lu-Ann Papile; Jill E Baley; William Benitz; James Cummings; Waldemar A Carlo; Eric Eichenwald; Praveen Kumar; Richard A Polin; Rosemarie C Tan; Kasper S Wang Journal: Pediatrics Date: 2014-06 Impact factor: 7.124
Authors: M Thoresen; J Penrice; A Lorek; E B Cady; M Wylezinska; V Kirkbride; C E Cooper; G C Brown; A D Edwards; J S Wyatt Journal: Pediatr Res Date: 1995-05 Impact factor: 3.756
Authors: Peter D Gluckman; John S Wyatt; Denis Azzopardi; Roberta Ballard; A David Edwards; Donna M Ferriero; Richard A Polin; Charlene M Robertson; Marianne Thoresen; Andrew Whitelaw; Alistair J Gunn Journal: Lancet Date: 2005 Feb 19-25 Impact factor: 79.321
Authors: Denis Azzopardi; Brenda Strohm; Neil Marlow; Peter Brocklehurst; Aniko Deierl; Oya Eddama; Julia Goodwin; Henry L Halliday; Edmund Juszczak; Olga Kapellou; Malcolm Levene; Louise Linsell; Omar Omar; Marianne Thoresen; Nora Tusor; Andrew Whitelaw; A David Edwards Journal: N Engl J Med Date: 2014-07-10 Impact factor: 91.245
Authors: Monica E Lemmon; Renee D Boss; Sonia L Bonifacio; Audrey Foster-Barber; A James Barkovich; Hannah C Glass Journal: J Child Neurol Date: 2016-12-20 Impact factor: 1.987
Authors: Joanne O Davidson; Alexandra L Rout; Guido Wassink; Caroline A Yuill; Frank G Zhang; Colin R Green; Laura Bennet; Alistair J Gunn Journal: J Cereb Blood Flow Metab Date: 2015-07-15 Impact factor: 6.200
Authors: Tadeu A Fantaneanu; Rani Sarkis; Kathleen Avery; Benjamin M Scirica; Shelley Hurwitz; Galen V Henderson; Jong Woo Lee Journal: Neurocrit Care Date: 2017-06 Impact factor: 3.210